The primary objective of this study is to assess the tolerability and safety of administration of PfSPZ-LARC2 Vaccine, with special attention to the adequacy of attenuation.
Research
Research Areas
Grants & Contracts
Clinical Trials
News & Events
About NIAID
Website Policies and Notices